Live Breaking News & Updates on Kedar Gautambhai Mehta

Stay updated with breaking news from Kedar gautambhai mehta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Colchicine No Benefit Over Supportive Care for COVID-19

Colchicine does not seem to offer benefit over supportive care for management of patients with COVID-19. ....

Kedar Gautambhai Mehta , College Gotri , Healthday News , Gautambhai Mehta ,

Colchicine No Benefit Over Supportive Care for COVID-19

No significant reduction reported in mortality, ventilatory support, ICU admission, length of stay, serious adverse events; increase seen in adverse events, diarrhea. ....

Kedar Gautambhai Mehta , College Gotri , Healthday News , Gautambhai Mehta ,

Does Meta-Analysis Slam the Door on Colchicine for COVID-19?

Pooled data showed no mortality benefit and higher risk of adverse events ....

United States , Zaina Hamza , Kedar Gautambhai Mehta , College Gotri , Medpage Today , Covid 19 ,

'Misleading' Results in Colchicine COVID-19 Trials Meta-Analysis

In a meta-analysis of six studies evaluating colchicine as a COVID-19 treatment, the anti-inflammatory drug for acute gout attacks did not appear to improve outcomes for patients. ....

New York , United States , Michaelh Pillinger , Kedar Gautambhai Mehta , Grossman School Of Medicine , Medscape Coronavirus Resource Center , College Gotri , Coronavirus Resource , Randomised Evaluation , Gautambhai Mehta , Very Different , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Uman Coronavirus Hku1 , Uman Coronavirus Oc43 , Cov Oc43 , Uman Coronavirus 229e , Cov 229e , Meta Analysis , Covid 19 Treatment , Health Care Quality Access Evaluation , Social Determinants Of Health , Anti Inflammatory Agents , Intensive Care Unit Icu , Intensive Care Unit ,